copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Pioneering Transformative T-Cell Therapies | Lyell At Lyell, we are driven by our mission and focused on developing transformative therapies to improve the lives of patients Join our team of ambitious Lyellites who are committed to defeating cancer through innovation
Our Team - Lyell Lyell is a clinical-stage cell therapy company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors
Careers | Lyell Search through our open positions to see what career opportunities are available
Our Story | Lyell Lyell is a clinical-stage cell therapy company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors
Our Cell Therapies | Lyell Lyell is committed to developing safe and effective CAR T-cell therapies for patients with cancer Our goal is to provide our therapies to patients at the appropriate time and in a clinically appropriate manner
Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase . . . Lyell is currently enrolling a Phase 1 clinical trial evaluating a first-generation ROR1-targeted CAR T-cell therapy enhanced with anti-exhaustion technology in patients with relapsed refractory triple-negative breast cancer, non-small cell lung cancer (NSCLC), ovarian cancer and endometrial cancer
Our Science - Lyell Lyell’s genetic reprogramming technologies are designed to delay T-cell exhaustion and create more potent T cells with enhanced, durable antitumor activity in the immunosuppressive tumor microenvironment